文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

治疗性纳米递药系统的毒理学特征

Toxicological profile of therapeutic nanodelivery systems.

机构信息

Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), FI-00014 University of Helsinki, Finland.

出版信息

Curr Drug Metab. 2012 Oct;13(8):1068-86. doi: 10.2174/138920012802850047.


DOI:10.2174/138920012802850047
PMID:22380014
Abstract

Several of the newly developed drug molecules show potent biological activity, but exhibit poor pharmacokinetic properties that may hinder their effective delivery to the intended site of action. In order to improve their pharmacological effect, these molecules can be associated with drug carriers in order to overcome these inherent difficulties. An ideal drug delivery agent requires therefore biocompatibility, improved solubility of a loaded drug or peptide, releasing of the payload at the absorption site and, at the same time, leaving undisturbed cell structure and function, and maintaining the physiological milieu. By taking advantage of the valuable properties of nanoscale delivery systems, such as increased surface area, improved solubility of hydrophobic drugs, possibility to encapsulate and protect drugs from degradation and reduced immunogenic potential and toxicological effect, new therapeutic options can be brought forth and improve the clinical arsenal for numerous diseases. The use of nanodelivery systems can even promote the re-investigation of pharmacokinetically less favourable, but biologically more active compounds. Although very promising, these systems may also encompass inherent toxicological issues, mainly due to their size and shape, physical interaction with cellular membranes and organelles, immunological reactions, long- or short-term tissue accumulation, and degradation products. Pharmaceutical nanodelivery systems, such as liposomes, polymeric nanoparticles, dendrimers and mesoporous silica and silicon based nanoparticles have shown great potential in preclinical applications and several of these nanosystems are even undergoing clinical trials. They have been found to combine drug delivery properties with an acceptable toxicological profile, which has made them prime candidates for several drug delivery approaches. This review aims to provide and correlate the toxicological studies with the drug delivery properties of the above mentioned nanodelivery systems in particular concerning uptake and accumulation as well as the critical aspects in each system regarding their optimal performance, while pointing out to the most relevant references.

摘要

几种新开发的药物分子表现出很强的生物活性,但表现出较差的药代动力学特性,这可能会阻碍它们有效递送到预期的作用部位。为了提高它们的药理作用,可以将这些分子与药物载体结合,以克服这些固有困难。因此,理想的药物递送剂需要具有生物相容性、提高载药或肽的溶解度、在吸收部位释放有效载荷,同时不干扰细胞结构和功能,并保持生理环境。利用纳米递药系统的宝贵特性,如增加表面积、提高疏水性药物的溶解度、封装和保护药物免受降解的可能性,以及降低免疫原性和毒理学效应,可以带来新的治疗选择,并为许多疾病增加临床武器库。纳米递药系统的应用甚至可以促进对药代动力学较差但生物学活性更高的化合物的重新研究。尽管这些系统非常有前途,但它们也可能包含固有的毒理学问题,主要是由于它们的大小和形状、与细胞膜和细胞器的物理相互作用、免疫反应、长期或短期的组织积累以及降解产物。脂质体、聚合物纳米颗粒、树枝状大分子和介孔硅及硅基纳米颗粒等药物纳米递药系统在临床前应用中显示出巨大的潜力,其中一些纳米系统甚至正在进行临床试验。它们被发现将药物递送特性与可接受的毒理学特征结合在一起,这使它们成为几种药物递送方法的首选候选物。本综述旨在提供和关联上述纳米递药系统的毒理学研究与药物递送特性,特别是关于摄取和积累,以及每个系统在最佳性能方面的关键方面,同时指出最相关的参考文献。

相似文献

[1]
Toxicological profile of therapeutic nanodelivery systems.

Curr Drug Metab. 2012-10

[2]
Nanodelivery of bioactive components for food applications: types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles.

Annu Rev Food Sci Technol. 2014-1-2

[3]
Silicon-polymer hybrid materials for drug delivery.

Future Med Chem. 2009-9

[4]
Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.

Expert Opin Drug Metab Toxicol. 2015-3

[5]
Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.

J Colloid Interface Sci. 2017-11-22

[6]
Dendronized Systems for the Delivery of Chemotherapeutics.

Adv Cancer Res. 2018-5-18

[7]
Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.

Int J Pharm. 2017-11-13

[8]
Nanoengineered drug delivery systems for enhancing antibiotic therapy.

J Pharm Sci. 2015-3

[9]
Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.

Curr Pharm Des. 2017

[10]
Mesoporous systems for poorly soluble drugs.

Int J Pharm. 2012-9-8

引用本文的文献

[1]
Multi-epitope ligand-conjugated nanoparticles for tumor neoantigen targeting: advancing molecular precision in cancer immunotherapy.

Med Oncol. 2025-8-11

[2]
USE OF ARTIFICIAL CELLS AS DRUG CARRIERS.

Mater Chem Front. 2021-9-21

[3]
Ultrasmall iron-gallic acid coordination polymer nanodots with antioxidative neuroprotection for PET/MR imaging-guided ischemia stroke therapy.

Exploration (Beijing). 2023-1-17

[4]
Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon.

Pharmaceutics. 2020-3-2

[5]
Evaluation of potential acute cardiotoxicity of biodegradable nanocapsules in rats by intravenous administration.

Toxicol Res (Camb). 2015-10-5

[6]
Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer.

Pharm Res. 2017-1

[7]
Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord.

J Control Release. 2013-3-18

[8]
Nanostructured porous Si-based nanoparticles for targeted drug delivery.

Biomatter. 2012

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索